Skip to content

The risk prediction and pathway study of abdominal skin injury after focused ultrasound ablation of uterine fibroids

The risk prediction and pathway study of abdominal skin injury after focused ultrasound ablation of uterine fibroids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067228
Enrollment
Unknown
Registered
2022-12-30
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine fibroids

Interventions

Focused ultrasound ablation surgery review group:N/A
Focused ultrasound ablation surgery prospective group:N/A

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Retrospective study: (1) Women of childbearing age with clinically and radiologically confirmed uterine fibroids; (2) Single or multiple uterine fibroids; (3) Preoperative MRI examination (including plain scan and enhanced scan) with complete imaging data; (4) Hysterography was performed after the operation. 2. Prospective research: (1) Women of childbearing age with clinically and radiologically confirmed uterine fibroids; (2) Single or multiple uterine fibroids; (3) Preoperative MRI examination (including plain scan and enhanced scan) with complete imaging data; (4) MRI examination was performed after surgery.

Exclusion criteria

Exclusion criteria: 1. Retrospective study: Unwilling or unable to follow up. 2. Prospective research: (1) The clinical diagnosis is unclear; (2) MRI scan contraindications; (3) Rapid enlargement of uterine fibroids in a short period of time or imaging evidence of malignant tendency or uncertain malignant potential; (4) Acute skin infection in the treated area; (5) Uncontrolled acute pelvic inflammation; (6) The general condition is poor, with serious dysfunction of heart, liver, kidney and other important organs; (7) With severe blood coagulation dysfunction; (8) Large area of skin scar in the treated area of the lower abdomen; (9) Unable to use sedative, analgesic and other related drugs; (10) Enlarged uterine fibroids after menopause; (11) Pedicled subserous fibroids, pedicled submucosal fibroids or cervical fibroids; (12) Unwillingness or inability to follow up.

Design outcomes

Primary

MeasureTime frame
the reaction of abdominal skin;the reaction in treated area;the presentation of abdominal skin;the MR T2WI signal of abdominal skin;the volume of ablation;satisfaction with treatment;classification of sedation;

Secondary

MeasureTime frame
sacrococcygeal reaction;the MR T2WI signal of Sacro tail;abdominal pain;pain score;abdominal scar;age;body mass indexI;characteristics of fibroids;

Countries

China

Contacts

Public ContactTang Chendian

Suining Central Hospital

tangchendian2008@126.com+86 13982500746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026